SANTINI GINO 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Aug 19, 2025
Insider Transaction Report
Form 4
SANTINI GINO
Director
Transactions
- Sale
Common Stock
2025-08-15$37.19/sh−5,405$201,018→ 95,042 total - Exercise/Conversion
Common Stock
2025-08-15$13.45/sh+15,000$201,750→ 100,447 total - Exercise/Conversion
Stock Option (Right to Purchase)
2025-08-15−15,000→ 0 totalExercise: $13.45Exp: 2025-09-10→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.17 to $37.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option is fully vested and exercisable.